Categories: Health

Anne Wojcicki buys 23andme and his data for $ 305 million,

23Andme founder Anne Wojcicki speaks on June 10, 2025 during a reform committee for supervision and reform of the government in Washington, DC.

Andrew Harnik | Getty pictures

Anne Wojcicki, the co-founder and former CEO of 23Andme, has regained control of the competitive genetic test company according to her new non-profit TTAM Research Institute Outbid Regeneron pharmaceuticalsThe company announced Friday.

TTAM will essentially acquire all assets of 23Ande for $ 305 million, including the business limits for personal genome service and research services as well as the subsidiary of telemedicine subsidiary Lemonaid. It is a great victory for Wojcicki, who resigned from her role as CEO when 23Andme submitted insolvency protection in Chapter 11 in March.

Last month, Regeneron announced that it would purchase most of the 23 -amm assets for $ 256 million after it was ahead during an insolvency auction. But Wojcicki submitted a separate offer of 305 million US dollars via TTAM and urged to reopen the auction. According to Wall Street Journal, TTAM is an abbreviation for the first letters from 23Andme.

“I am thrilled that the TTAM research institute can continue the 23Andme mission to help people access, understand and benefit from human genome,” said Wojcicki in an explanation.

Due to his DNA test kits, 23Andme gained popularity at home, which gave customers an insight into their family history and genetic profiles. In 2021, the five -time CNBC Disruptor 50 Company went to the stock exchange with a merger with a special company for purposes. At its climax, 23Andme had a value of around 6 billion US dollars.

The company tried to generate recurring earnings and to face the public for viable research and therapists, and it was plagued by data protection concerns, since Hacker accessed the information from almost 7 million customers in 2023.

The acquisition of TTAM is still subject to the approval of the US insolvency court for the eastern district of Missouri.

Do not miss these findings from CNBC Pro

Times Reporter

Recent Posts

Access to the abortion pill mifepristone remains stable under Trump, with an FDA review pending

Mifepristone and misoprostol pills are pictured on Wednesday, October 3, 2018, in Skokie, Illinois.Erin Holey…

4 hours ago

Study shows prescription of GLP-1 drugs has increased sharply after birth

Danish researchers examined medication use during and after pregnancy and found a clear trend: the…

1 day ago

Novo Nordisk shares fall after Alzheimer’s drug trial fails to meet target

A view shows a Novo Nordisk sign in front of its office in Bagsvaerd, on…

2 days ago

Airlines say air traffic will reach record levels on Thanksgiving

A traveler checks flight information at LAX as the shutdown passes the one-month mark and…

3 days ago

No longer overlooked: Sabina Spielrein, visionary between Freud and Jung

This article is part of Overlooked, a series of obituaries about notable people whose deaths…

4 days ago

Derek Hough on Hayley Erbert’s Pregnant Emotions

Derek Hough is always in sync with Hayley Erbert. So much so that the "Dancing…

4 days ago

This website uses cookies.